ECNP 2026 Preview: Emerging Psychiatric Therapies and Competitive Trends
ECNP 2026 at a glance At ECNP 2026, where will the next wave of psychiatric…
Neuroscience Strategic Roundup: From Efficacy to Differentiation | Aug 25–Sept 29, 2026
Current neuroscience trends point to a broader competitive shift, as treatment…
AbbVie–Iambic AI Drug Discovery Collaboration: Strategic Implications | Lucid Diligence Brief
This Lucid Diligence Brief examines the AbbVie–Iambic AI drug discovery…
Neuroscience Strategic Roundup | June17–July 21, 2026
Strategic Developments and Competitive Shifts in Neuroscience Coverage Period:…
Lucid Diligence Brief: Teva to acquire Emalex Biosciences
Lucid Diligence Brief: Teva to acquire Emalex Biosciences Professional…
Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million financing
Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million…
Lucid Diligence Brief: Eli Lilly acquires Centessa Pharmaceuticals
Lucid Diligence Brief: Eli Lilly acquires Centessa Pharmaceuticals Professional…
Lucid Diligence Brief: Otsuka to acquire Transcend Therapeutics
Lucid Diligence Brief: Otsuka to acquire Transcend Therapeutics Professional…
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on genetic epilepsies
Lucid Diligence Brief: Angelini Pharma collaboration with Quiver Bioscience on…
Healthcare and Pharma Industry Trends H2 2025: From Innovation to Execution
An in-depth analysis of pharma and healthcare industry trends in H2 2025,…
Lucid Diligence Brief: Novartis and SciNeuro BBB “brain-shuttle” Alzheimer’s deal
Lucid Diligence Brief: Novartis and SciNeuro BBB “brain-shuttle” Alzheimer’s…
Top Neuroscience News: Video summary (Oct 1 –14, 2025)
This top neuroscience news video summary covers Pier 88 Health &…